Geographic trial intelligence
Where psychedelic trials happen
Explore registry-reported psilocybin and psilocin study sites, then compare recruitment status, phase, indication, sponsor, design, and timing without losing the geographic context.
299trial records
447mapped sites
25countries
135open or upcoming
Auto-updated after scheduled ClinicalTrials.gov refreshesRegistry facts checked Aug 10, 2026 01:26 UTC
1 · Explore geography
Research sites
Preparing the indexed trial geography…
Open or upcoming
Active, closed to recruitment
Completed
Stopped or unknown
Circle size = trials at site
Building the trials map…
Map and list will remain synchronized as you filter.
How to read this: one trial can appear at several sites. Markers represent registry-reported facilities with coordinates, not participant eligibility or real-time appointment availability. Select a marker to focus its trials.
3 · Compare the evidence landscape
Research lens
Summaries update with the map, making geographic concentration and study maturity visible before record-level review.
Preparing a concise interpretation of the selected evidence landscape…
4 · Review records
Trial records
Registry facts only; descriptions and source payloads are not redistributed.
Refine phase, condition, intervention, substance, or datesNo advanced filters
Interpretation and provenance
Built for discovery, not recruitment advice
Statuses, dates, enrollment, and locations are factual fields reported by study sponsors to ClinicalTrials.gov and can lag local site changes. Confirm every decision in the linked registry record and with the study team.
The page exposes an allowlisted projection only: titles, identifiers, sponsors, study design facts, dates, interventions, conditions, and site coordinates. Abstracts, registry descriptions, source-derived keywords, contacts, and raw payloads remain excluded.
Geographic context: Natural Earth, public domain. Boundaries do not imply a position on legal status or sovereignty. Collection rules and corrections are documented in the editorial policy.